![](/img/cover-not-exists.png)
Lorcaserin treatment decreases body weight and improves cardiometabolic risk factors of obese adults: A 6‐month‐long, randomized, placebo‐controlled, double‐blind clinical trial
Tuccinardi, Dario, Farr, Olivia M., Upadhyay, Jagriti, Oussaada, Sabrina M., Mathew, Hannah, Paschou, Stavroula A., Perakakis, Nikolaos, Koniaris, Anastasia, Kelesidis, Theodoros, Mantzoros, ChristosLanguage:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.13655
Date:
February, 2019
File:
PDF, 280 KB
english, 2019